ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Progression-free survival in neuroendocrine tumors: preferred end point, but how should it be defined?

Rachel P Riechelmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.